iOrganBio
Chapel Hill, North Carolina, United States · Biotechnology · 9 employees
iOrganBio is transforming human cell production with CellForge™, its AI-powered platform for consistent, scalable, and intelligent manufacturing of cells and organoids for in vitro modeling and cell therapies. By applying engineering precision to biology, CellForge uses AI and automation to guide cell development and make real-time adjustments aligned with defined biological profiles. At the core
Funding history
- Series seed — $2.0M — Oct 2025
Recent signals
- Jan 28, 2026: iOrganBio Appoints Karol Jarzabek as Chief Operating Officer
- Oct 29, 2025: Raised $2.0M in Series seed
See plans & pricing → Track iOrganBio’s funding, hiring, and signals — with verified contacts — on Fundz.